Journal article

Warfarin for atrial fibrillation: the end of an era?

GA Donnan, HM Dewey, BR Chambers

The Lancet Neurology | ELSEVIER SCIENCE INC | Published : 2004

DOI: 10.1016/S1474-4422(04)00738-0

Citation metrics

27Web of Science
34Scopus
29Dimensions

Keywords

Risk Factors
Aspirin
Science & Technology
Idraparinux
Ximelagatran
Anticoagulants
Anticoagulation
Treatment Outcome
Death
Humans
Stroke Prevention
Clinical Neurology
Atrial Fibrillation
Drug Therapy, Combination
Antithrombotic Therapy
Stroke
Risk
Rhythm Control
Life Sciences & Biomedicine
Warfarin
Fibrinolytic Agents
Neurosciences & Neurology
Prevalence